The Global Immune Thrombocytopenia Drugs Market is expected to reach 3.86 billion by 2030 from 2.45 billion USD in 2021, growing at a CAGR of 1.2% from 2022 to 2030.
There are no reviews for this PDF.
There are no comments for this PDF.
You must log in to post a comment.
Log in